| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JNEUROIM.2010.09.014 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0165572810004339?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:S0165572810004339?httpAccept=text/xml | ||
| P3181 | OpenCitations bibliographic resource ID | 4707494 |
| P698 | PubMed publication ID | 20943276 |
| P50 | author | Christian Geis | Q89247282 |
| Trygve Holmøy | Q64539783 | ||
| P2860 | cites work | Vulnerability of human neurons to T cell-mediated cytotoxicity | Q73552887 |
| Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase | Q73720580 | ||
| Pathological evidence of encephalomyelitis in the stiff man syndrome with anti-GAD antibodies | Q74395832 | ||
| T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity | Q74666138 | ||
| Physiologic studies of spinal inhibitory circuits in patients with stiff-person syndrome | Q74800963 | ||
| GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient | Q77756392 | ||
| Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase | Q78115533 | ||
| Specific antibody index in cerebrospinal fluid from patients with central and peripheral paraneoplastic neurological syndromes | Q79577556 | ||
| Analysis of multiple sclerosis cerebrospinal fluid reveals a continuum of clonally related antibody-secreting cells that are predominantly plasma blasts | Q81588164 | ||
| GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence | Q81661292 | ||
| Successful treatment with rituximab in a patient with stiff-person syndrome complicated by dysthyroid ophthalmopathy | Q82716989 | ||
| Stiff person syndrome associated with lower motor neuron disease and infiltration of cytotoxic T cells in the spinal cord | Q84251277 | ||
| Monozygotic twins with stiff person syndrome and autoimmune thyroiditis: rituximab inefficacy in a double-blind, randomised, placebo controlled crossover study | Q84393835 | ||
| Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome | Q21136358 | ||
| The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer | Q24680318 | ||
| Autoimmunity to gephyrin in Stiff-Man syndrome | Q28145724 | ||
| Autoimmunity in stiff-Man syndrome with breast cancer is targeted to the C-terminal region of human amphiphysin, a protein similar to the yeast proteins, Rvs167 and Rvs161 | Q28247444 | ||
| Decreased synaptic vesicle recycling efficiency and cognitive deficits in amphiphysin 1 knockout mice | Q28510217 | ||
| Synaptic vesicle endocytosis impaired by disruption of dynamin-SH3 domain interactions | Q30176576 | ||
| Treatment of stiff person syndrome with rituximab. | Q30494071 | ||
| Distinct antigenic features of linear epitopes at the N-terminus and C-terminus of 65 kDa glutamic acid decarboxylase (GAD65): implications for autoantigen modification during pathogenesis | Q30854842 | ||
| Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome | Q33258079 | ||
| Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. | Q33656297 | ||
| The structural era of endocytosis | Q33683033 | ||
| The stiff man and stiff man plus syndromes | Q33719054 | ||
| Characterization of CD4+ T cells specific for glutamic acid decarboxylase (GAD65) and proinsulin in a patient with stiff-person syndrome but without type 1 diabetes | Q33884262 | ||
| Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes | Q34159440 | ||
| Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus | Q34172103 | ||
| Demonstration of functional coupling between gamma -aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles | Q34183366 | ||
| Central nervous system destruction mediated by glutamic acid decarboxylase-specific CD4+ T cells | Q34338895 | ||
| Control of glial immune function by neurons | Q34398649 | ||
| The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome | Q34512042 | ||
| Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase | Q34566310 | ||
| Advances in the pathogenesis and treatment of patients with stiff person syndrome | Q34589713 | ||
| High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome | Q34719788 | ||
| GAD treatment and insulin secretion in recent-onset type 1 diabetes | Q34848774 | ||
| Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase | Q35049679 | ||
| Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica | Q35234452 | ||
| Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia | Q35461004 | ||
| Humoral and cellular immune parameters before and during immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus. | Q36318504 | ||
| Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity | Q36318955 | ||
| Neuropathology and binding studies in anti-amphiphysin-associated stiff-person syndrome | Q48248500 | ||
| Transport of CSF antibodies to Galpha subunits across neural membranes requires binding to the target protein and protein kinase C activity. | Q48270983 | ||
| Mild experimental autoimmune encephalitis as a tool to induce blood-brain barrier dysfunction | Q48394980 | ||
| Progressive encephalomyelitis with rigidity | Q48400148 | ||
| Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients | Q48405596 | ||
| Stiff-man syndrome: possible autoimmune etiology targeted against GABA-ergic cells | Q48664998 | ||
| Stiff person syndrome: advances in pathogenesis and therapeutic interventions | Q48751128 | ||
| Stiff-man syndrome and encephalomyelitis. Report of a case | Q48858727 | ||
| Subacute encephalomyelitis presenting as stiff-person syndrome: clinical, polygraphic, and pathologic correlations | Q48880483 | ||
| Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL. | Q48894792 | ||
| Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin | Q48924908 | ||
| Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis | Q48949365 | ||
| Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients | Q49029367 | ||
| Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. | Q51689887 | ||
| Idiotope-specific CD4(+) T cells induce apoptosis of human oligodendrocytes. | Q51793479 | ||
| Humoral and Cellular Autoimmune Responses in Stiff Person Syndrome | Q52956428 | ||
| Genetics of susceptibility and resistance to insulin-dependent diabetes in stiff-man syndrome. | Q54193067 | ||
| Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus. | Q55034045 | ||
| Stiff man syndrome: clinical and laboratory findings in eight patients. | Q55065966 | ||
| High-Dose Intravenous Immune Globulin for Stiff-Person Syndrome | Q59649757 | ||
| Psychological factors in the diagnosis and pathogenesis of stiff-man syndrome | Q60639987 | ||
| Constitutive endocytosis of GABAA receptors by an association with the adaptin AP2 complex modulates inhibitory synaptic currents in hippocampal neurons | Q73119677 | ||
| Microglia induce myelin basic protein-specific T cell anergy or T cell activation, according to their state of activation | Q73129199 | ||
| Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. | Q36363509 | ||
| Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice | Q36399066 | ||
| Sudden death and paroxysmal autonomic dysfunction in stiff-man syndrome | Q36405363 | ||
| B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation | Q36485715 | ||
| The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes | Q36535592 | ||
| The role of the synthetic enzyme GAD65 in the control of neuronal gamma-aminobutyric acid release | Q36563300 | ||
| BAR, F-BAR (EFC) and ENTH/ANTH domains in the regulation of membrane-cytosol interfaces and membrane curvature | Q36580060 | ||
| The stiff leg syndrome | Q36900963 | ||
| Stiff-man syndrome associated with nocturnal myoclonus and epilepsy | Q37059507 | ||
| Immunobiology of stiff-person syndrome | Q37094697 | ||
| Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease | Q37179065 | ||
| Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs | Q37290484 | ||
| Antigen processing patterns determine GAD65-specific regulation vs. pathogenesis | Q37409952 | ||
| Tissue-mediated control of immunopathology in coeliac disease | Q37638199 | ||
| Amphiphysin I and regulation of synaptic vesicle endocytosis | Q37662707 | ||
| A patient with reflex myoclonus and muscle rigidity: "jerking stiff-man syndrome". | Q39244168 | ||
| A selective activity-dependent requirement for dynamin 1 in synaptic vesicle endocytosis | Q39752213 | ||
| Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. | Q39770767 | ||
| Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome | Q39913279 | ||
| Multiple sclerosis: glatiramer acetate induces anti-inflammatory T cells in the cerebrospinal fluid. | Q39963593 | ||
| Stiff-person syndrome following West Nile fever | Q40531353 | ||
| Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patient | Q40607014 | ||
| IgG-immunostaining in the intact rabbit brain: variable but significant staining of hippocampal and cerebellar neurons with anti-IgG. | Q40622375 | ||
| Suppressive effect of glutamic acid decarboxylase 65-specific autoimmune B lymphocytes on processing of T cell determinants located within the antibody epitope | Q40720812 | ||
| Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome | Q41196484 | ||
| Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics | Q41790064 | ||
| Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome | Q41994256 | ||
| Unique luminal localization of VGAT-C terminus allows for selective labeling of active cortical GABAergic synapses | Q42605038 | ||
| Stiff-person syndrome: persistent elevation of glutamic acid decarboxylase antibodies despite successful treatment with rituximab | Q43006057 | ||
| Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis | Q43076381 | ||
| Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies | Q43734068 | ||
| Immunoglobulin Fc gamma receptor promotes immunoglobulin uptake, immunoglobulin-mediated calcium increase, and neurotransmitter release in motor neurons | Q44059830 | ||
| Selective extraction of small and large molecules from the cerebrospinal fluid by Purkinje neurons | Q44333123 | ||
| Dual impairment of GABAA- and GABAB-receptor-mediated synaptic responses by autoantibodies to glutamic acid decarboxylase | Q44363790 | ||
| Myelin antigen reactive T cells in cerebrovascular diseases | Q44501927 | ||
| Direct impact of T cells on neurons revealed by two-photon microscopy in living brain tissue. | Q44795497 | ||
| GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65. | Q44876645 | ||
| Amphiphysin autoimmunity: paraneoplastic accompaniments | Q45130801 | ||
| Stiff person syndrome associated anti-amphiphysin antibodies reduce GABA associated [Ca(2+)]i rise in embryonic motoneurons. | Q45920186 | ||
| Reversibility of cerebellar GABAergic synapse impairment induced by anti-glutamic acid decarboxylase autoantibodies | Q46555940 | ||
| Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients | Q46815045 | ||
| Serum antibodies in epilepsy and seizure-associated disorders | Q46848031 | ||
| Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome | Q47671744 | ||
| Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases | Q48122020 | ||
| Autoantigenic properties of native and denatured glutamic acid decarboxylase: evidence for a conformational epitope | Q48153660 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| P304 | page(s) | 55-60 | |
| P577 | publication date | 2010-10-12 | |
| 2011-02-01 | |||
| P1433 | published in | Journal of Neuroimmunology | Q15716691 |
| P1476 | title | The immunological basis for treatment of stiff person syndrome | |
| P478 | volume | 231 |
| Q44842014 | A complex case of anti-GAD antibody-related syndrome treated with Rituximab |
| Q37410906 | Anti-glutamic acid decarboxylase antibody positive neurological syndromes |
| Q26753841 | Clinical Spectrum of Stiff Person Syndrome: A Review of Recent Reports |
| Q37924701 | Conventional apheresis therapies: a review |
| Q41107258 | Evaluation of Treatment Outcomes in Patients with Stiff Person Syndrome with Rituximab vs. Standard of Care |
| Q48661821 | Human IgG directed against amphiphysin induces anxiety behavior in a rat model after intrathecal passive transfer |
| Q35729575 | Immune mediated diseases and immune modulation in the neurocritical care unit |
| Q89881773 | Improvement of stiff-person syndrome symptoms in pregnancy: Case series and literature review |
| Q42530496 | Interactions of Human Autoantibodies with Hippocampal GABAergic Synaptic Transmission - Analyzing Antibody-Induced Effects ex vivo |
| Q28072253 | Neuronal central nervous system syndromes probably mediated by autoantibodies |
| Q33734422 | Stiff-person syndrome: case series |
Search more.